menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Estrogen and heart disease

close
Estrogen and heart disease
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    The government funding prospective study of the safety and efficacy of hormone replacement therapy in the menopause practically stopped the routine prescription of estrogen overnight. Why? Our guest today is Dr. Richard Karas, Professor of Medicine, at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The government funding prospective study of the safety and efficacy of hormone replacement therapy in the menopause practically stopped the routine prescription of estrogen overnight. Why? Our guest today is Dr. Richard Karas, Professor of Medicine, at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/9/20